RecruitingNot ApplicableNCT06867484

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Breast Re-irradiation After Second Ipsilateral Lumpectomy (BRASIL Trial)


Sponsor

Youssef Zeidan

Enrollment

114 participants

Start Date

Oct 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.


Eligibility

Sex: FEMALEMin Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study tests re-irradiation (a second course of radiation therapy) after a second lumpectomy for women who have had a breast cancer recurrence in the same breast (ipsilateral recurrence) but have already received radiation before. **You may be eligible if...** - You are 40 years of age or older - You have been diagnosed with ER-positive, HER2-negative breast cancer - You have had a second lumpectomy for a recurrence in the same breast - At least 18 months have passed since your last breast radiation treatment - Your cancer has a low genomic risk score (Oncotype low or ultra-low) **You may NOT be eligible if...** - Your cancer has spread to lymph nodes or distant organs - You have a BRCA gene mutation - You are pregnant - Your remaining breast tissue after surgery is too limited for radiation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONIntensity modulated radiation therapy (IMRT)

40 Gy total in 15 consecutive weekday sessions to the partial breast


Locations(2)

Lynn Cancer Institute at Baptist Health, Inc.

Boca Raton, Florida, United States

Miami Cancer Institute at Baptist Health, Inc.

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06867484


Related Trials